It looks like PTC Therapeutics will have to carry out another clinical trial of its drug candidate for inherited neuromuscular disorder Friedreich's ataxia (FA) before the FDA will consider approval.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(Alliance News) - Creo Medical Group PLC said on Friday it plans to raise GBP5.5 million through a placing and is seeking to sell its remaining 49% stake in Creo Medical Europe SL, as the company ...

Creo Medical Group PLC (AIM:CREO, FRA:1RC, OTC:CMEOF) announced plans to raise approximately £5.5 million through a placing as the medical device company moves to strengthen its balance sheet while ...

PTC Therapeutics has abandoned its latest attempt to secure FDA approval for Duchenne muscular dystrophy (DMD) treatment Translarna, after the FDA said it was unlikely to approve the drug based on the ...

DiRico reaffirmed fiscal '26 constant currency ARR growth guidance of 7.5%–9.5% excluding Kepware and ThingWorx, and 7%–9% including them. She said, "In Q2, for constant currency ARR excluding Kepware ...

DENVER (KDVR) — The Colorado Department of Revenue revealed on Wednesday how much eligible Coloradans can receive through its PTC Rebate Program and unveiled a new tax credit for Coloradans with ...

Aug 19 (Reuters) - The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' (PTCT.O), opens new tab oral medication for a rare genetic disorder with limited treatment options, ...

Creo 12 brings a host of features designed to address common product development challenges. This release introduces more than 250 updates intended to improve engineering workflows and efficiency.

Autodesk Inc. is weighing an acquisition of rival engineering-software provider PTC Inc., according to people familiar with the matter. Autodesk has been working with advisers to evaluate a ...